Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases

Molecular Medicine

Volumn 3, Issue 10, 1997, Pages 695-707

  Barelli, Hélène ^a   Lebeau, Anthony ^a   Vizzavona, Jean ^b   Delaere, Pia ^c   Chevallier, Nathalie ^a   Drouot, Cyril ^c   Marambaud, Philippe ^a   Ancolio, Karine ^a   Buxbaum, Joseph D ^d   Khorkova, Olga ^c   Heroux, Jeff ^c   Sahasrabudhe, Sudhir ^c   Martinez, Jean ^b   Warter, Jean Marie ^e   Mohr, Michel ^f   Checler, Frédéric ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b CNRS   (France)

^c SANOFI   (France)

^d ROCKEFELLER UNIVERSITY   (United States)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^f Institut de Pathologie Strasbourg   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BRAIN DISEASE; GENE MUTATION; IMMUNOHISTOCHEMISTRY; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RABBIT; VASCULAR AMYLOIDOSIS;

EID: 14444267540     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401708     Document Type: Article

References (42)

1. Hardy J, Allsop D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12: 383-388.
2. Glenner GG, Wong CW. (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120: 885-890.
3. Masters CL, Simons G, Weinman NA, et al. (1985) Amyloid plaque core protein in Alzheimer's Disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82: 4245-4249.
4. Checler F. (1995) Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65: 1431-1444.
5. Selkoe DJ. (1994) Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17: 489-517.
6. Burdick D, Soreghan B, Kwon M, et al. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267: 546-554.
7. Jarrett JT, Berger EP, Lansbury P, Jr. (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32: 4693-4697.
8. Mullan M, Crawford F, Axelman K, et al. (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet. 1: 345-347.
9. Citron M, Oltersdorf T, Haass C, et al. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360: 672-674.
10. Cai X-D, Golde TE, Younkin SG. (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259: 514-516.
11. Felsenstein KM, Hunihan LW, Roberts SB. (1994) Altered cleavage and secretion of a recombinant β-APP bearing the Swedish familial Alzheimer's disease mutation. Nature Genet. 6: 251-256.
12. Tanzi RE, St. George-Hyslop P, Gusella JF. (1991) Molecular genetics of Alzheimer disease amyloid. J. Biol. Chem. 266: 20579-20582.
13. Mullan M, Crawford F. (1993) Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16: 398-403.
14. Suzuki N, Cheung TT, Cai X-D, et al. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264: 1336-1340.
15. Levy-Lahad E, Wasco W, Poorkaj P, et al. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973-977.
16. Rogaev EI, Sherrington R, Rogaeva EA, et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775-778.
17. Sherrington R, Rogaev EI, Liang Y, et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760.
18. Borchelt DR, Thinakaran G, Eckman, et al. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 in vitro and in vivo. Neuron 17: 1005-1013.
19. Citron M, Westaway D, Xia W, et al. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3: 67-72.
20. Duff K, Eckman C, Zehr C, et al. (1996) Increased amyloid-β42(43) in brains expressing mutant presenilin 1. Nature 383: 710-713.
21. Matsueda GR, Stewart JM. (1981) A p-methylbenzhydrylamine resin for improved solid-phase synthesis of peptides amides. Peptides 2: 45-50.
22. Cucumel C, Garreau I, Mery J, et al. (1996) Production and characterization of site-directed antibodies against dermorphin and dermorphin-related peptides. Peptides 17: 973-982.
23. Checler F, Barelli H, Vincent JP. (1989) Tissue distribution of a novel neurotensin-degrading metallopeptidase. An immunological approach using monospecific polyclonal antibodies. Biochem. J. 257: 549-554.
24. Schägger H, Von Jagow G. (1987) Tricinesodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166: 368-379.
25. Chevallier N, Jiracek J, Vincent B, et al. (1997) Examination of the role of endopeptidase 3.4.24.15 in Aβ secretion by human transfected cells. Br. J. Pharmacol. 121: 556-562.
26. Marambaud P, Chevallier N, Barelli H, et al. (1997) Proteasome contributes to the α-secretase pathway of amyloid precursor protein in human cells. J. Neurochem. 68: 837-845.
27. Delaere P, He Y, Fayet G, et al. (1993) βA4 deposits are constant in the brain of the oldest old: An immunocytochemical study of 20 French centenarians. Neurobiol. Aging 14: 191-194.
28. Caporaso L, Gandy SE, Buxbaum JD, et al. (1992) Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89: 3055-3059.
29. Efthimiopoulos S, Felsenstein KM, Sambamurti K, et al. (1994) Study of the phorbol ester effect on Alzheimer amyloid precursor processing: Sequence requirements and involvement of a cholera toxin sensitive protein. J. Neurosci. Res. 38: 81-90.
30. Gillespie S, Golde TE, Younkin SG. (1992) Secretory processing of the Alzheimer amyloid β/A4 protein precursor is increased by protein phosphorylation. Biochem. Biophys. Res. Commun. 187: 1285-1290.
31. Slack BE, Nitsch RM, Livneh E, et al. (1993) Regulation by phorbol esters of amyloid precursor protein release from Swiss 3T3 fibroblasts overexpressing protein kinase Ca. J. Biol. Chem. 268: 21097-21101.
32. Mori H, Takio K, Ogawara M, et al. (1992) Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J. Biol. Chem. 267: 17082-17086.
33. Miller DL, Papayannopoulos IA, Styles J, et al. (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301: 41-52.
34. Roher AE, Lowenson JD, Clarke S, et al. (1993) Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and statibility in Alzheimer's disease. J. Biol. Chem. 268: 3072-3083.
35. Iwatsubo T, Mann DMA, Odaka A, et al. (1995) Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37: 294-299.
36. Iwatsubo T, Odaka A, Suzuki N, et al. (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron 13: 45-53.
37. Cummings BJ, Satou T, Head E, et al. (1996) Diffuse plaques contain C-terminal Aβ42 and not Aβ40: Evidence from cats and dogs. Neurobiol. Aging 17: 653-659.
38. Nakamura S, Tamaoka A, Sawamura N, et al. (1995) Carboxyl end-specific monoclonal antibodies to amyloid β protein (Aβ) subtypes (Aβ40 and Aβ42(43)) differentiate Aβ in senile plaques and amyloid angiopathy in brains of aged cynomolgus monkeys. Neurosci. Lett. 201: 151-154.
39. Fukumoto H, Asami-Odaka A, Suzuki N, et al. (1996) Amyloid β protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Am. J. Pathol. 148: 259-265.
40. Roher AE, Lowenson JD, Clarke S, et al. (1993) β-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 10836-10840.
41. Joachim CL, Duffy LK, Morris JH, et al. (1988) Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging. Brain Res. 474: 100-111.
42. Prelli F, Castano E, Glenner GG, et al. Differences between vascular and plaque core amyloid in Alzheimer's disease. J. Neurochem. 51: 648-651.